Back to Search
Start Over
MO40-3 Impact of acquired RAS, BRAF and PIK3CA mutation at 8 weeks on the efficacy of anti- EGFR monoclonal antibodies in mCRC.
- Source :
-
Annals of Oncology . Oct2024:Supplement 3, Vol. 35, pS1348-S1348. 1p. - Publication Year :
- 2024
- Subjects :
- *BRAF genes
*MONOCLONAL antibodies
*EPIDERMAL growth factor receptors
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 180495655
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.07.583